Pricing Log in Create free account

Dogwood Therapeutics, Inc (DWTX) vs Sangamo Therapeutics, Inc. (SGMOQ)

Dogwood Therapeutics, Inc and Sangamo Therapeutics, Inc. are both Biotechnology companies. Dogwood Therapeutics, Inc and Sangamo Therapeutics, Inc. are of similar size ($42.5M and $41.9M). Dogwood Therapeutics, Inc has the higher net margin (0.00% vs −356.9%) and the lower return on invested capital (−41.2% vs 0.00%). Across the 11 metrics below, Dogwood Therapeutics, Inc leads on 7 and Sangamo Therapeutics, Inc. on 4.

Valuation

Metric DWTX SGMOQ Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.24 9.71
P/B 0.61 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 1.24 9.21
Earnings yield (733.61%) (345.45%) (33.15%)
Free cash flow yield (36.28%) (211.06%) (25.50%)

Profitability

Metric DWTX SGMOQ Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (357.55%) 0.00%
Net margin 0.00% (356.89%) 0.00%
Free cash flow margin 0.00% (261.76%) 0.00%
Return on equity (143.45%) 1,755.72% (56.36%)
Return on assets (40.68%) (168.79%) (48.04%)
Return on invested capital (41.22%) 0.00% 0.00%

Growth

Metric DWTX SGMOQ Biotechnology median
Revenue growth (TTM) — (45.80%) 6.02%
EPS growth (last fiscal year) 43.05% 10.20% 30.26%
Revenue growth, 5-year CAGR — (19.66%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DWTX SGMOQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.89 0.70 4.72
Net debt to EBITDA 0.23 0.18 0.96

Dividend

Metric DWTX SGMOQ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DWTX SGMOQ Biotechnology median
Market cap 42.49m 41.89m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack